LRIG1 and cervical carcinoma: Likewise, future retrospective and prospective studies in independent, larger cohorts will be necessary to assess whether LRIG1, either alone or in combination with other biomarkers, can reliably predict lymph node metastasis in early‐stage cervical carcinoma in a clinically meaningful way.